MICER: a resource to help understand disease

Making sense of the mouse genome

MICER: a resource to help understand disease

micer-chromosomes.jpg

With the sequencing of the mouse genome at The Wellcome Trust Sanger Institute and other centres nearing completion, an extensive and increasingly accurate catalogue of mouse genes is available. The mouse gene set will work to help us understand the function of human genes in health and disease.

A major route to understanding how genes work is to study the effects of mutations in which the gene is disrupted. Although several methods are available to produce mutations in the mouse genome, new methods are needed to alter genes in a high-throughput manner.

MICER (Mutagenic Insertion and Chromosome Engineering Resource) - detailed in Nature Genetics online today (4 July 2004) - is a novel tool for targeted modification of the mouse genome. It is based on the mouse genome sequence: randomly defined sections of the mouse genome have been joined to a DNA molecule that can disrupt normal gene activity. When introduced into mouse cells, the mouse sequence in this molecule will often find its corresponding sequence in the genome and disrupt it.

"This is a tool that will allow researchers to exploit the high-quality genome sequence produced by the Mouse Genome Sequencing Consortium. We believe it will make a real difference to our understanding of the workings of genes in health and disease."

Dr David Adams, leader of the MICER Project at The Wellcome Trust Sanger Institute

MICER dramatically reduces the time to go from a DNA region implicated in disease to modelling and understanding that disease. It allows researchers to modify one gene at a time, to produce duplications of genes or regions or to delete genes or regions. All these techniques are crucial for turning genomic information into health benefit.

"Delivery of high-quality genome sequences is only the first step towards improving human health. With these first steps, we can now move to developing entirely new ways of investigating genetic activity and the part that genes play in health and disease. MICER will help biomedical research to move more quickly towards that new understanding."

Professor Allan Bradley, Director of the Wellcome Trust Sanger Institute

micer-ensembl.png
MICER: a resource to help understand disease

MICER is an early realization of the commitment of The Wellcome Trust Sanger Institute to enable researchers to make use of the human and mouse genome sequences. A key component of the project is the collection of nearly 100,000 DNA clones that target discrete regions of the mouse genome. On the average, there is one clone every 39,000 base-pairs.

The resource is freely available and the team are developing cell lines with vectors targeted to selected regions of the genome. The saving in research time is remarkable: in minutes, a researcher can identify and source reagents that would take weeks or months to make in the lab.

The team are now making a new set of cloned DNAs to target a larger proportion of genes: this phase is expected to be completed within 12 months.

But MICER, available as it has been developed, has already been put to use. James R. Lupski, Cullen Professor of Molecular and Human Genetics and Professor of Pediatrics at Baylor College of Medicine, has used MICER to engineer mouse models for genomic disorders (diseases due to rearrangements of the human genome).

"MICER combines the awesome power of bioinformatics and genomics with 'wet-bench' biology, enabling high-throughput, experimental-based functional genomics."

James R. Lupski, Cullen Professor of Molecular and Human Genetics and Professor of Pediatrics at Baylor College of Medicine

MICER complements other resources announced in the past two months by the Sanger Institute: the Sanger Institute Gene Trap Resource (SIGTR) provides a set of mutations in identified genes and a new approach announced on 23 June 2004 provides a novel method to mutate both copies of a gene. Freely available resources such as MICER and SIGTR will help to improve efficiencies in modelling disease.

The Sanger Institute, with its expertise in high-throughput biology and DNA sequencing is well placed to provide these resources for the biomedical community. These advances will make it easier for scientists to overcome the first hurdle in designing their experiment and ultimately this will accelerate the discovery process.

Notes to Editors
Publications
  • Mutagenic insertion and chromosome engineering resource (MICER).

    Adams DJ, Biggs PJ, Cox T, Davies R, van der Weyden L et al.

    Nature genetics 2004;36;8;867-71

Participants

Utilities
Publication details

Senior authors - David Adams and Allan Bradley

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7748 379849

Recent News

Researchers identify new possibilities for the treatment of inflammatory bowel disease
Two molecular pathways found to be integral to maintaining balance in the digestive system
Root of childhood kidney cancer discovered
Pre-cancerous signatures found in healthy tissue point the way towards new treatment options
From childhood cancer to mapping human development: Pioneering scientist awarded 2019 Foulkes Foundation medal
Congratulations to Professor Muzlifah Haniffa, who has been recognised for her work on the immune system and childhood cancer